An antimicrobial metabolite n- hexadecenoic acid from marine sponge-associated bacteria Bacillus subtilis effectively inhibited biofilm forming multidrug-resistant P. aeruginosa .
Arya SajayanAmrudha RavindranJoseph SelvinPrathiviraj RagothamanGeorge Seghal KiranPublished in: Biofouling (2023)
Effective drug candidates to obstruct the emergence of multidrug-resistant pathogens have become a major concern. A potent antimicrobial producer was isolated from a marine sponge designated as MSI38 and was identified as Bacillus subtilis by 16SrDNA sequencing. The active antimicrobial fraction was purified, and the metabolite was identified as n-hexadecanoic acid by spectroscopic analysis. The fish-borne pathogen Pseudomonas aeruginosa FP012 was found to be multidrug-resistant and poses a risk of disease to food handlers and consumers in general. The compound showed a potent bactericidal effect against P. aeruginosa FP012 with a MIC of 31.33 ± 5.67 mg L -1 and MBC of 36.66 ± 5.17 mg L -1 . The time-based biofilm inhibitory potential of MSI38 and ciprofloxacin was analyzed by confocal laser scanning microscopy. A synergistic effect of MSI38 and ciprofloxacin on biofilm showed 85% inhibition.
Keyphrases
- pseudomonas aeruginosa
- bacillus subtilis
- multidrug resistant
- acinetobacter baumannii
- gram negative
- staphylococcus aureus
- drug resistant
- biofilm formation
- cystic fibrosis
- klebsiella pneumoniae
- candida albicans
- high resolution
- optical coherence tomography
- high speed
- single molecule
- human health
- single cell
- anti inflammatory
- molecular docking
- emergency department
- risk assessment
- drug delivery
- mass spectrometry
- drug induced
- molecular dynamics simulations
- antimicrobial resistance